Hot of the Press: Lopinavir–Ritonavir NOT Effective in Severe COVID19 NEJM

Dr RR Baliga's "Got Knowledge Doc" Podkast
18/03/2020 5 min
Hot of the Press: Lopinavir–Ritonavir NOT Effective in Severe COVID19 NEJM

Listen "Hot of the Press: Lopinavir–Ritonavir NOT Effective in Severe COVID19 NEJM"

Descargar episodio Ver en sitio original

Episode Synopsis

Hot of the Press: Lopinavir–Ritonavir NOT Effective in Severe COVID19 NEJM March 18, 2020 Dr RR Baliga's 'Got Knowledge Doc' Podcasts for Physicians Not Medical Advice or Opinion

More episodes of the podcast Dr RR Baliga's "Got Knowledge Doc" Podkast

Stroke Risk, Stent Benefit, Surgical Uncertainty 🧠✨🔧 22/11/2025
UPFs, Diets, Disease: The Global Drift 🍔➡️🌍➡️⚠️ 21/11/2025
Groceries, Guidance, Gains 🛒📞📉 — How DASH Delivery Lowers Blood Pressure 20/11/2025
Hemodialysis, Cardiovascular Burden, Therapeutic Hope 🩺❤️🌊 — Can Omega-3 Fatty Acids Bend the Risk Trajectory? 19/11/2025
💊 Oral, Potent, Proven — Enlicitide Redefines LDL Control 18/11/2025
One Cup of Coffee. Less Atrial Fib/Flutter. More Life ☕🌀➡️💛 17/11/2025
Beyond the Culprit: Complete Revascularisation • Fewer Deaths • Better Futures 💖🩺✨ 16/11/2025
Olezarsen Cuts Triglycerides. Calms Pancreas. Changes Outcomes. 🧬🔥🛡️ 15/11/2025
MI Aftercare: The Beat Goes On—With or Without Beta-Blockers 🥁➡️❤️ 14/11/2025
NOAC Monotherapy Wins in Afib with Drug Eluting Stents: Safer, Stronger, Smarter ⚖️🔥🧠 13/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA